ImmunityBio's chart data is dated 2026-10-09. Recorded technical signals: MA aligned. There are 5 published signal records.
ImmunityBio last closed at $10.51 (+6.05%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -10.5×. Its overall grade ranks 7 of 738 stocks in Healthcare.
About this company
ImmunityBio last closed at $10.51 (+6.05%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 7/738
Valuation grade A+
Related stocks
- NantKwestRelated theme
ImmunityBio와 같은 창업자·기술축(면역치료)에서 형성된 핵심 연계 기업
- Bristol-Myers SquibbCompetitor
면역항암제·세포치료 영역에서 경쟁하는 대형 제약사
- MerckCompetitor
종양면역치료 시장에서 경쟁하는 대표 빅파마
ETFs holding this stock
Golden Eagle Dynamic Hypergrowth ETF
Details →About ImmunityBio
- What technical signals does ImmunityBio (IBRX) have?
- ImmunityBio current technical signals: MA alignment (score 0.81).
- Is ImmunityBio a cup-and-handle pattern?
- No. ImmunityBio has no valid Cup signal right now.
- What published figures are available for ImmunityBio?
- Market cap: $10.35B. Trailing 12 months PER: -10.5×. Latest quarter PBR: -9.95×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about ImmunityBio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.